Document is current
Any future updates will be listed below
-
Authors
Miyazaki, Celine https://orcid.org/0000-0002-0224-563X
Masuda, Junya
Tsai, Phiona I-Ching
Saeki, Hidehisa
-
Funding
Funding for this research was provided by:
Janssen Japan
- License Information
-
More Information
Article History
Received: 29 July 2024
Accepted: 4 September 2024
First Online: 15 October 2024
Declarations
:
: Celine Miyazaki, Junya Masuda, and Phiona I-Ching Tsai are employees of Janssen Pharmaceutical K.K., Japan and may own stock in Johnson & Johnson. Hidehisa Saeki has received lecture fees from Mitsubishi Tanabe Pharma Corporation, Taiho Pharmaceutical Co., Ltd., Torii Pharmaceutical Co. Ltd., Maruho Co., Ltd., Kyowa Kirin Co., Ltd., AbbVie GK, Novartis Pharma K.K., Eli Lilly Japan K.K., LEO Pharma K.K., Celgene Corp., Janssen Pharmaceutical K.K., and UCB Japan Co. Ltd. and/or research costs from Maruho Co., Ltd, AbbVie GK, and LEO Pharma K.K; and/or scholarship donations from Taiho Pharmaceutical Co., Ltd., Maruho Co., Ltd., Eisai Co., Ltd., and Sun Pharma Japan Ltd.
: All required approvals and permissions for data extraction from the JMDC database and performing pre-specified analyses were obtained. The study used de-identified patient data and was conducted in compliance with all laws and regulations, national guidelines, and other standards regarding the handling of personal information. Informed consent and ethics committee approval were not applicable based on the Ethical Guidelines for Epidemiological Research issued by the Japanese Ministry of Health, Welfare and Labor.
